The Inhalation Anesthetics Market is expected to register a CAGR of 4.7% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Inhalation Anesthetics Market report covers analysis by Product (Sevoflurane, Desflurane, Isoflurane); Application (Induction, Maintenance), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.
Purpose of the ReportThe report Inhalation Anesthetics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Inhalation Anesthetics Market Segmentation
Product- Sevoflurane
- Desflurane
- Isoflurane
- Induction
- Maintenance
Strategic Insights
Inhalation Anesthetics Market Growth Drivers- Growing Surgical Procedures Worldwide: Chronic diseases like cancer, cardiovascular issues, and orthopedic conditions are rising due to factors such as sedentary lifestyles, aging populations, and genetic predispositions. These diseases often require surgical intervention, creating a sustained demand for anesthetics. Inhalation anesthetics are preferred in many cases for their ability to induce and maintain anesthesia quickly and effectively. The increase in elective and emergency surgeries globally, coupled with technological advancements in surgical techniques, has further amplified the market demand.
- Advancements in Anesthesia Delivery Systems: Modern anesthesia machines are equipped with state-of-the-art features like integrated monitoring, real-time gas analysis, and automated dosing. These innovations ensure the accurate administration of inhalation anesthetics, reducing the risk of overdosage or complications. They also enable better utilization of anesthetic agents, minimizing wastage and cost, which appeals to healthcare facilities aiming for operational efficiency. In August 2023, Mindray launched A Series Anesthesia Systems, improving patient safety and operational efficiency. AnaeSight™ is Mindray's revolutionary solution for combined intravenous-inhalational anesthesia (CIVIA), which integrates anesthesia machines, patient monitors, and pumps to centrally control both intravenous and inhalational anesthetics.
- Rising Geriatric Population: The global population aged 65 and older is increasing, especially in developed regions like Europe, North America, and parts of Asia. Older adults are more likely to suffer from age-related conditions such as arthritis, cardiovascular disease, and fractures, which often require surgical treatment. In June 2023, Lunan Pharmaceutical Group obtained marketing authorization from the Netherlands Committee for Drug Evaluation for sevoflurane for inhalation. This general anesthetic agent is used for adult and pediatric patients. Approvals are expected in Germany and Spain shortly after that. That would be the second product by Lunan that gains approval in the Netherlands. Inhalation anesthetics are effective in managing anesthesia in this demographic due to their controllable depth of sedation and rapid recovery profiles, minimizing postoperative complications.
- Movement to Environment-Friendly Anesthetic Agents: Desflurane and nitrous oxide inhalation agents are linked with greenhouse gas effects due to emissions into the atmosphere. There has been a change toward less impactful environmental agents such as sevoflurane. Anesthetic agents like sevoflurane, along with technology such as closed-circuit anesthesia systems implemented in hospitals and manufacturing, cut anesthetic gas emissions into the atmosphere.
- Increasing Popularity of Sevoflurane: Among anesthetics, sevoflurane has also been widely accepted for low pungency, rapid induction, and recovery. Pediatric and outpatient procedures require quick recovery of the patient and a safe anesthesia profile, which makes sevoflurane a good alternative. In terms of efficiency, healthcare facilities make sevoflurane in increasing demand.
- Focus on Pediatric and Neonatal Anesthesia: The anesthesia in children and neonates differs as the latter needs unique physiology-related applications. Companies are creating unique formulation and delivery devices especially to accommodate pediatric needs and sedation efficacy without exposing the young patient to dangers. It has emerged as an upcoming market trend in recent years.
- Development of Low-GWP Agents: Sustainability in the environment is now a concern in healthcare. The manufacturers have an opportunity to design anesthetic agents with low GWP and clinical effectiveness. This will align with global sustainability initiatives and address concerns over the environment in the use of inhalation anesthetics.
- Strategic Collaborations and Partnerships: Partnerships between pharmaceutical companies and healthcare providers can accelerate the adoption of advanced anesthetic solutions. Collaborations often focus on training programs, co-development of technologies, and clinical trials, which facilitate market penetration and establish trust among healthcare professionals.
- Expansion of Anesthesia Services in Rural Areas: In many developing regions, rural healthcare facilities lack access to advanced anesthesia services. By addressing these gaps, manufacturers can significantly expand their market reach. Affordable and portable anesthesia systems tailored for low-resource settings can further drive growth in these underserved areas.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Inhalation Anesthetics Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Inhalation Anesthetics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The major factors driving the Inhalation Anesthetics Market are Growing Surgical Procedures Worldwide, Advancements in Anesthesia Delivery Systems, and Rising Geriatric Population
The key future trends of the market are Movement to Environment-Friendly Anesthetic Agents, Increasing Popularity of Sevoflurane, and Focus on Pediatric and Neonatal Anesthesia
The leading players operating in the Inhalation Anesthetics Market include Abbott, AbbVie Inc., Baxter International, Eisai Co., Ltd., Fresenius Kabi AG, Halocarbon Products Corporation, Hikma Pharmaceuticals PLC, Jiangsu Hengrui Medicine Co. Ltd., Luman Pharmaceutical Group Co., Ltd.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on the request are an additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Inhalation Anesthetics Market - By Product
1.3.2 Inhalation Anesthetics Market - By Application
1.3.3 Inhalation Anesthetics Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INHALATION ANESTHETICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INHALATION ANESTHETICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. INHALATION ANESTHETICS MARKET - GLOBAL MARKET ANALYSIS
6.1. INHALATION ANESTHETICS - GLOBAL MARKET OVERVIEW
6.2. INHALATION ANESTHETICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. INHALATION ANESTHETICS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. SEVOFLURANE
7.3.1. Overview
7.3.2. Sevoflurane Market Forecast and Analysis
7.4. DESFLURANE
7.4.1. Overview
7.4.2. Desflurane Market Forecast and Analysis
7.5. ISOFLURANE
7.5.1. Overview
7.5.2. Isoflurane Market Forecast and Analysis
8. INHALATION ANESTHETICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. INDUCTION
8.3.1. Overview
8.3.2. Induction Market Forecast and Analysis
8.4. MAINTENANCE
8.4.1. Overview
8.4.2. Maintenance Market Forecast and Analysis
9. INHALATION ANESTHETICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Inhalation Anesthetics Market Overview
9.1.2 North America Inhalation Anesthetics Market Forecasts and Analysis
9.1.3 North America Inhalation Anesthetics Market Forecasts and Analysis - By Product
9.1.4 North America Inhalation Anesthetics Market Forecasts and Analysis - By Application
9.1.5 North America Inhalation Anesthetics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Inhalation Anesthetics Market
9.1.5.1.1 United States Inhalation Anesthetics Market by Product
9.1.5.1.2 United States Inhalation Anesthetics Market by Application
9.1.5.2 Canada Inhalation Anesthetics Market
9.1.5.2.1 Canada Inhalation Anesthetics Market by Product
9.1.5.2.2 Canada Inhalation Anesthetics Market by Application
9.1.5.3 Mexico Inhalation Anesthetics Market
9.1.5.3.1 Mexico Inhalation Anesthetics Market by Product
9.1.5.3.2 Mexico Inhalation Anesthetics Market by Application
9.2. EUROPE
9.2.1 Europe Inhalation Anesthetics Market Overview
9.2.2 Europe Inhalation Anesthetics Market Forecasts and Analysis
9.2.3 Europe Inhalation Anesthetics Market Forecasts and Analysis - By Product
9.2.4 Europe Inhalation Anesthetics Market Forecasts and Analysis - By Application
9.2.5 Europe Inhalation Anesthetics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Inhalation Anesthetics Market
9.2.5.1.1 Germany Inhalation Anesthetics Market by Product
9.2.5.1.2 Germany Inhalation Anesthetics Market by Application
9.2.5.2 France Inhalation Anesthetics Market
9.2.5.2.1 France Inhalation Anesthetics Market by Product
9.2.5.2.2 France Inhalation Anesthetics Market by Application
9.2.5.3 Italy Inhalation Anesthetics Market
9.2.5.3.1 Italy Inhalation Anesthetics Market by Product
9.2.5.3.2 Italy Inhalation Anesthetics Market by Application
9.2.5.4 Spain Inhalation Anesthetics Market
9.2.5.4.1 Spain Inhalation Anesthetics Market by Product
9.2.5.4.2 Spain Inhalation Anesthetics Market by Application
9.2.5.5 United Kingdom Inhalation Anesthetics Market
9.2.5.5.1 United Kingdom Inhalation Anesthetics Market by Product
9.2.5.5.2 United Kingdom Inhalation Anesthetics Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Inhalation Anesthetics Market Overview
9.3.2 Asia-Pacific Inhalation Anesthetics Market Forecasts and Analysis
9.3.3 Asia-Pacific Inhalation Anesthetics Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Inhalation Anesthetics Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Inhalation Anesthetics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Inhalation Anesthetics Market
9.3.5.1.1 Australia Inhalation Anesthetics Market by Product
9.3.5.1.2 Australia Inhalation Anesthetics Market by Application
9.3.5.2 China Inhalation Anesthetics Market
9.3.5.2.1 China Inhalation Anesthetics Market by Product
9.3.5.2.2 China Inhalation Anesthetics Market by Application
9.3.5.3 India Inhalation Anesthetics Market
9.3.5.3.1 India Inhalation Anesthetics Market by Product
9.3.5.3.2 India Inhalation Anesthetics Market by Application
9.3.5.4 Japan Inhalation Anesthetics Market
9.3.5.4.1 Japan Inhalation Anesthetics Market by Product
9.3.5.4.2 Japan Inhalation Anesthetics Market by Application
9.3.5.5 South Korea Inhalation Anesthetics Market
9.3.5.5.1 South Korea Inhalation Anesthetics Market by Product
9.3.5.5.2 South Korea Inhalation Anesthetics Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Inhalation Anesthetics Market Overview
9.4.2 Middle East and Africa Inhalation Anesthetics Market Forecasts and Analysis
9.4.3 Middle East and Africa Inhalation Anesthetics Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Inhalation Anesthetics Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Inhalation Anesthetics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Inhalation Anesthetics Market
9.4.5.1.1 South Africa Inhalation Anesthetics Market by Product
9.4.5.1.2 South Africa Inhalation Anesthetics Market by Application
9.4.5.2 Saudi Arabia Inhalation Anesthetics Market
9.4.5.2.1 Saudi Arabia Inhalation Anesthetics Market by Product
9.4.5.2.2 Saudi Arabia Inhalation Anesthetics Market by Application
9.4.5.3 U.A.E Inhalation Anesthetics Market
9.4.5.3.1 U.A.E Inhalation Anesthetics Market by Product
9.4.5.3.2 U.A.E Inhalation Anesthetics Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Inhalation Anesthetics Market Overview
9.5.2 South and Central America Inhalation Anesthetics Market Forecasts and Analysis
9.5.3 South and Central America Inhalation Anesthetics Market Forecasts and Analysis - By Product
9.5.4 South and Central America Inhalation Anesthetics Market Forecasts and Analysis - By Application
9.5.5 South and Central America Inhalation Anesthetics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Inhalation Anesthetics Market
9.5.5.1.1 Brazil Inhalation Anesthetics Market by Product
9.5.5.1.2 Brazil Inhalation Anesthetics Market by Application
9.5.5.2 Argentina Inhalation Anesthetics Market
9.5.5.2.1 Argentina Inhalation Anesthetics Market by Product
9.5.5.2.2 Argentina Inhalation Anesthetics Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. INHALATION ANESTHETICS MARKET, KEY COMPANY PROFILES
11.1. ABBOTT
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ABBVIE INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BAXTER INTERNATIONAL
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. EISAI CO., LTD.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. FRESENIUS KABI AG
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. HALOCARBON PRODUCTS CORPORATION
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. HIKMA PHARMACEUTICALS PLC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. JIANGSU HENGRUI MEDICINE CO. LTD.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. LUMAN PHARMACEUTICAL GROUP CO., LTD
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. PIRAMAL ENTERPRISES LIMITED
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. Abbott
2. AbbVie Inc.
3. Baxter International
4. Eisai Co., Ltd.
5. Fresenius Kabi AG
6. Halocarbon Products Corporation
7. Hikma Pharmaceuticals PLC
8. Jiangsu Hengrui Medicine Co. Ltd.
9. Luman Pharmaceutical Group Co., Ltd
10. Piramal Enterprises Limited
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For